Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1128-1137

  Spealman, Roger D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; BROMOCRIPTINE; COCAINE; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; ECOPIPAM; EMONAPRIDE; ETICLOPRIDE; N (1 BENZYL 3 PYRROLIDINYL) 5 CHLORO 4 CYCLOPROPYLCARBONYLAMINO 2 METHOXYBENZAMIDE; N (1 BENZYL 3 PYRROLIDINYL) 5 CHLORO 4 CYCLOPROPYLCARBOXAMIDO 2 METHOXYBENZAMIDE; NAXAGOLIDE; PROPYLNORAPOMORPHINE; QUINPIROLE; UNCLASSIFIED DRUG; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H (1)BENZOPYRANO(4,3 B) 1,4 OXAZIN 9 OL; 3,4,4A,10B-TETRAHYDRO-4-PROPYL-2H,5H-(1)BENZOPYRANO(4,3-B)-1,4-OXAZIN-9-OL; BENZOPYRAN DERIVATIVE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRD3 PROTEIN, HUMAN; OXAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG SCREENING; MALE; NONHUMAN; PRIORITY JOURNAL; SQUIRREL MONKEY; ANIMAL; CEBIDAE; CELL CULTURE; DISCRIMINATION LEARNING; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; MITOSIS;

ANIMALS; BENZOPYRANS; CELLS, CULTURED; COCAINE; DISCRIMINATION LEARNING; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; MALE; MITOSIS; OXAZINES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SAIMIRI;

EID: 0030302460     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. 3 receptor ligands. Eur. J. Pharmacol. 281: R7-R9, 1995.
2. 3 receptor agonist ligand, to CHO-K1 cells. Life Sci. 57: 1401-1410, 1995.
3. 2 dopamine receptor antagonists in squirrel monkeys. J. Pharmacol. Exp. Ther. 258: 910-917, 1991.
4. 2 receptor mRNA. Brain Res. 564: 203-219, 1991.
5. BUNZOW, J. R., VANTOL, H. H. M., GRANDY, D. K., ALBERT, P., SALON, J., CHRISTIE, M., MACHIDA, C. A., NEVE, K. A. AND CIVELLI, O.: Cloning and expression of a rat dopamine receptor. Nature (Lond.) 336: 783-787, 1988.
6. 3 dopamine receptors. Neuropsychopharmacology 12: 335-345, 1995.
7. CAINE, S. B. AND KOOB, G. F.: Modulation of cocaine self-administration in the rat through D-3 dopamine receptors. Science (Wash. DC) 260: 1814-1816, 1993.
8. CAINE, S. B. AND KOOB, G. F.: Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat. Behav. Pharmacol. 6: 333-347, 1995.
9. CUNNINGHAM, K. A. AND CALLAHAN, P. M.: Neurobehavioral pharmacology of cocaine: Role of serotonin in its locomotor and discriminative stimulus effects. Natl. Inst. Drug Abuse Res. Monogr. Ser. 145: 40-66, 1994.
10. DALY, S. A. AND WADDINGTON, J. L.: Behavioural effects of the putative D-3 dopamine receptor agonist 7-OH-DPAT in relation to other "D-2-like" agonists. Neuropharmacology 32: 509-510, 1993.
11. 1 dopamine receptor. Nature (Lond.) 347: 72-76, 1990.
12. 3 selective compound, PD 128907. Soc. Neurosci. Abstr. 19: 77, 1993.
13. 3 receptor agonist. Behav. Pharmacol. 5: 106-107, 1994.
14. DWORKIN, S. I. AND SMITH, J. E.: Neurobehavioral pharmacology of cocaine. Natl. Inst. Drug Abuse Res. Monogr. Ser. 88: 185-198, 1988.
15. 3 dopamine receptor. J. Pharmacol. Exp. Ther. 268: 417-426, 1994.
16. 3 receptors in rat brain. Eur. J. Pharmacol. 211: 189-194, 1992.
17. 3 autoreceptor-mediated effects? Pharmacol. Biochem. Behav. 52: 275-280, 1995.
18. 3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. J. Pharmacol. Exp. Ther. 275: 899-913, 1995.
19. 2 dopamine receptor. Proc. Natl. Acad. Sci. U.S.A. 86: 9762-9766, 1989.
20. 3H]dopamine in rat brain tissue slices. Biochem. Pharmacol. 24: 847-852, 1975.
21. 4 receptors. Br. J. Pharmacol. 117: 1625-1632, 1996.
22. JAFFE, J. H.: Drug addiction and drug abuse. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, ed. by A. G. Gilman, L. S. Goodman, T. W. Rall and F. Murad, pp. 532-581, Macmillan, New York, 1985.
23. JOHANSON, C.-E. AND BARRETT, J. E.: The discriminative stimulus effects of cocaine in pigeons. J. Pharmacol. Exp. Ther. 267: 1-8, 1993.
24. JOHANSON, C.-E. AND FISCHMAN, M. W.: The pharmacology of cocaine related to its abuse. Pharmacol. Rev. 41: 3-52, 1989.
25. KENNEDY, L. T. AND HANBAUER, I.: Sodium-sensitive cocaine binding to rat striatal membranes: Possible relationship to dopamine uptake sites. J. Neurochem. 41: 172-178, 1983.
26. KLEVEN, M. S., ANTHONY, E. W. AND WOOLVERTON, W. L.: Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J. Pharmacol. Exp. Ther. 254: 312-317, 1990.
27. KOE, B. K: Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199: 649-661, 1976.
28. 3 receptor sites in rat brain: A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5: 145-153, 1993.
29. 3 receptors: Effects of ions and guanine nucleotides. J. Pharmacol. Exp. Ther. 274: 790-797, 1995.
30. MCKENNA, M. L. AND HO, B. T.: The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology 19: 297-303, 1980.
31. 3 receptors. Eur. J. Pharmacol. 249: R5-R6, 1993.
32. 2 receptors elicits prolactin secretion and catalepsy. J. Pharmacol. Exp. Ther. 275: 885-898, 1995.
33. NEGUS, S. S., BURKE, T. F., MEDZIHRADSKY, F. AND WOODS, J. H.: Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: Antagonism by quadazocine. J. Pharmacol. Exp. Ther. 267: 896-903, 1993.
34. PARSONS, L. H., CAINE, S. B., KOOB, G. F. AND WEISS, F.: The effects of the D-3 receptor agonist 7-OHDPAT on cocaine self-administration may be mediated postsynaptically. Behav. Pharmacol. 5: suppl. 1, 43, 1994.
35. 3 agonist PD 128907. J. Pharmacol. Exp. Ther. 275: 1355-1366, 1995.
36. 1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. J. Pharmacol. Exp. Ther. 267: 765-775, 1993.
37. 1 receptor agonists in squirrel monkeys. Eur. J. Pharmacol. 260: 237-241, 1994.
38. 2 receptors. NeuroReport 6: 329-332, 1995a.
39. 3 receptor antagonist, activates locomotion in rodents. J. Pharmacol. Exp. Ther. 275: 1239-1246, 1995b.
40. 3 receptors and σ sites in the bovine caudate nucleus. Eur. J. Pharmacol. 242: R1-R2, 1993.
41. SCHUSTER, C. R. AND JOHANSON, C. E.: The relationship between the discriminative stimulus properties and subjective effects of drugs. In Transduction Mechanisms of Drug Stimuli, ed. by F. C. Colpaert and R. L. Balster, pp. 161-175, Springer-Verlag, New York, 1988.
42. SEEMAN, P.: Receptor Tables, vol. 2, Drug Dissociation Constants for Neuroreceptors and Transporters, SZ Research, Toronto, 1993.
43. SEEMAN, P. AND VANTOL, H. M.: Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15: 264-270, 1994.
44. 2 receptor. Eur. J. Pharmacol. 225: 331-337, 1992.
45. 3) as a target for neuroleptics. Nature (Lond.) 347: 146-151, 1990.
46. SOKOLOFF, P. AND SCHWARTZ, J.-C.: Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16: 270-275, 1995.
47. SPEALMAN, R. D.: Use of cocaine discrimination techniques for preclinical evaluation of candidate therapeutics for cocaine dependence. Natl. Inst. Drug Abuse Res. Monogr. Ser. 119: 175-179, 1992.
48. SPEALMAN, R. D.: Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology 112: 93-99, 1993.
49. SPEALMAN, R. D.: Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 275: 53-62, 1995.
50. SPEALMAN, R. D., BERGMAN, J., MADRAS, B. K. AND MELIA, K. F.: Discriminative stimulus effects of cocaine in squirrel monkeys: Involvement of dopamine receptor subtypes. J. Pharmacol. Exp. Ther. 258: 945-953, 1991.
51. 1. Nature (Lond.) 350: 614-619, 1991.
52. 1 receptor encoded by an intronless gene on chromosome 5. Nature (Lond.) 347: 80-83, 1990.
53. 3 ligand (+)-7-OH-DPAT is independent of changes in dopamine release. J. Neural Transm. 95: 71-74, 1994.
54. 2 and receptor differentiation: A statistical analysis of competitive antagonists. Life Sci. 25: 637-654, 1979.
55. 4 dopamine receptors in fibroblast and dopaminergic cell lines. J. Pharmacol. Exp. Ther. 268: 495-502, 1994a.
56. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270: 475-479, 1994b.
57. 4 receptor with high affinity for the antipsychotic clozapine. Nature (Lond.) 360: 610-614, 1991.
58. WITKIN, J. M.: Pharmacotherapy of cocaine abuse: Preclinical development. Neurosci. Biobehav. Rev. 18: 121-142, 1994.
59. WITKIN, J. M., NICHOLS, D. E., TERRY, P. AND KATZ, J. L.: Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257: 706-713, 1991.
60. WOOLVERTON, W. L. AND JOHNSON, K. M.: Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13: 193-200, 1992.
61. 1 dopamine receptors. Nature (Lond.) 347: 76-79, 1990.